Noticias de PFE_US
Noticias del mercado
Últimas noticias sobre PFE_US — 665 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Los ingresos alcanzaron los 15.030 millones de dólares en el segundo trimestre, un 2,60 por ciento más que en 2025. Las acciones de Pfizer cuestan EUR
Pfizer (NYSE:PFE) sigue siendo el foco de atención a medida que la innovación sanitaria y la investigación farmacéutica siguen evolucionando.
$3,600,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.
En la última sesión de negociación, Pfizer (PFE) cerró a 30,11 dólares, lo que supone un movimiento del +2,28% respecto al día anterior.
Pfizer stock costs EUR 26.39 on October 20, 2026 versus the Xetra close. Q2 revenue reached USD 15.0
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pfizer develops medicines and vaccines across therapeutic areas. At Lang & Schwarz the stock trades
Price-action only: Pfizer Inc. (PFE) movements set the tone for institutional models. Precision Trading with Pfizer Inc. (PFE) Risk Zones
Pfizer reports results on November 3, 2026. Pfizer stock costs EUR 26.39 on October 19, 2026, up 0.3
Bristol-Myers Squibb Company (NYSE:BMY) looks cheaper than Pfizer Inc. (NYSE:PFE) on earnings, even though its latest revenue growth was stronger. That sounds like an easy valuation story until the profit figures enter the picture. Bristol Myers reported a 40% rise in second-quarter adjusted earnings per share, while Pfizer’s adjusted earnings were virtually unchanged. But those […]
Pfizer (NYSE:PFE) drew attention this week as its obesity push and the Metsera deal reshaped the pipeline, placing the drugmaker firmly in focus during pharma earnings season.
Pfizer reported USD 15.03 billion in second-quarter revenue. Pfizer stock costs EUR 26.29 on October
Pfizer develops medicines and vaccines, with an analyst webcast listed for November 3, 2026. At Lang
Las acciones de Pfizer cotizan a 26,30 EUR en las operaciones del fin de semana del 18 de octubre de 2026 frente a 26,30 EUR en el Xetr.
Página 12 de 34